Hematopoietic cell transplantation is a curative treatment for many hematologic malignancies and selected non-malignant hematologic, immunologic, and genetic disorders. Hematopoietic reconstitution is initially driven mainly by progenitor cells with limited long-term repopulating capacity, whereas reconstitution of the hematopoietic stem cell (HSC) compartment occurs more slowly. We hypothesized that this period of active hematopoietic regeneration may provide a favorable environment for the engraftment of subsequently transplanted HSCs. Mice underwent sequential transplantation with bone marrow cells carrying different CD45 allotypes. Long-term donor contribution was assessed in immature bone marrow cell populations and peripheral blood. HSCs engrafted during active hematopoietic regeneration showed superior long-term reconstitution, contributing a greater proportion of hematopoietic and immune cells than HSCs engrafted after myeloablative conditioning. An actively regenerating hematopoietic environment engrafts transplanted HSCs and enhances their long-term function in the production of blood and immune cells. These findings demonstrate that the timing and environmental context of engraftment are strongly associated with long-term stem cell performance. The mechanisms responsible for this effect remain to be determined. These findings have direct clinical potential.
No takes yet. Share an insight, caveat, or question.
Faltusová et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: